Cardiol Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRDL and other ETFs, options, and stocks.About CRDL
Cardiol Therapeutics, Inc. is a clinical-stage life sciences company focused on the research and clinical of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. Its lead product candidate, CardiolRx, is a pharmaceutically manufactured oral cannabidiol formulation that is being clinically developed for use in heart diseases.
CEODavid G. Elsley
CEODavid G. Elsley
Employees22
Employees22
HeadquartersOakville, Ontario
HeadquartersOakville, Ontario
Founded2017
Founded2017
Employees22
Employees22
CRDL Key Statistics
Market cap101.67M
Market cap101.67M
Price-Earnings ratio-2.93
Price-Earnings ratio-2.93
Dividend yield—
Dividend yield—
Average volume365.58K
Average volume365.58K
High today$1.12
High today$1.12
Low today$1.01
Low today$1.01
Open price$1.06
Open price$1.06
Volume439.81K
Volume439.81K
52 Week high$1.95
52 Week high$1.95
52 Week low$0.7709
52 Week low$0.7709
Stock Snapshot
The current Cardiol Therapeutics(CRDL) stock price is $1.03, with a market capitalization of 101.67M. The stock trades at a price-to-earnings (P/E) ratio of -2.93.
As of 2025-11-13, Cardiol Therapeutics(CRDL) stock has fluctuated between $1.01 and $1.12. The current price stands at $1.03, placing the stock +2.0% above today's low and -8.0% off the high.
The Cardiol Therapeutics(CRDL)'s current trading volume is 439.81K, compared to an average daily volume of 365.58K.
In the last year, Cardiol Therapeutics(CRDL) shares hit a 52-week high of $1.95 and a 52-week low of $0.77.
In the last year, Cardiol Therapeutics(CRDL) shares hit a 52-week high of $1.95 and a 52-week low of $0.77.
People also own
Based on the portfolios of people who own CRDL. This list is generated using Robinhood data, and it’s not a recommendation.